APA (7th ed.) Citation

Ruixin Gu, Wei Zhang, & Dandan Xu. (2022). Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ruixin Gu, Wei Zhang, and Dandan Xu. Stachydrine Is Effective and Selective Against Blast Phase Chronic Myeloid Leukaemia Through Inhibition of Multiple Receptor Tyrosine Kinases. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Ruixin Gu, et al. Stachydrine Is Effective and Selective Against Blast Phase Chronic Myeloid Leukaemia Through Inhibition of Multiple Receptor Tyrosine Kinases. Taylor & Francis Group, 2022.